Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control

Lancet

Volumn 347, Issue 9014, 1996, Pages 1514-1518

  Yamanouchi, Toshikazu ^a   Ogata, Nobuyuki ^a   Tagaya, Tetsuo ^a   Kawasaki, Takahiro ^a   Sekino, Nori ^a   Funato, Hirono ^a   Akaoka, Ieo ^a   Miyashita, Hideo ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 ANHYDROSORBITOL; FRUCTOSAMINE; GLIBENCLAMIDE; GLICLAZIDE; GLUCOSE; HEMOGLOBIN A1C; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SERUM;

EID: 0029941887     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90672-8     Document Type: Article

References (27)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
2. 1c in diabetes mellitus. N Engl J Med 1976; 295: 417-20.
3. Service FJ, O'Brien PC, Rizza RA. Measurements of glucose control. Diabetes Care 1987; 10: 225-37.
4. Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie S, Gould BJ. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycemia. Diabetologia 1990; 33: 208-15.
5. Nathan DM. Hemoglobin A1c - infatuation or the real thing? N Engl J Med 1990; 323: 1062-64.
6. Yamanouchi T, Akanuma H, Asano T, Konishi C, Akaoka I, Akanuma Y. Reduction and recovery of plasma 1,5-anhydro-D-glucitol level in diabetes mellitus. Diabetes 1987; 36: 709-15.
7. Yamanouchi T, Minoda S, Yabuuchi M, et al. Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients. Diabetes 1989; 38: 723-29.
8. Yamanouchi T, Akaoka I, Akanuma Y, Akanuma H, Miyashita H. Mechanism for acute reduction of 1,5-anhydro-D-glucitol in rats treated with diabetogenic agents. Am J Physiol 1990; 258: E423-27.
9. Kametani S, Hashimoto Y, Yamanouchi T, Akanuma Y, Akanuma H. Reduced renal reabsorption of 1,5-anhydroglucitol in diabetic rats and mice. J Biochem 1987; 102: 1599-607.
10. Yamanouchi T, Akanuma H, Nakamura T, Akoaka I, Akanuma Y. Reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients. Diabetologia 1988; 31; 41-45.
11. Akanuma Y, Morita M, Fukuzawa N, Yamanouchi T, Akanuma H. Urinary excretion of 1,5-anhydroglucitol accompanying glucose excretion in diabetic patients. Diabetologia 1988; 31: 831-35.
12. Yamanouchi T, Akanuma Y. Serum 1,5-anhydroglucitol (1,5AG): new clinical marker for glycemic control. Diabetes Res Clin Pract 1994; 24 (suppl): S261-68.
13. Yamanouchi T, Akanuma Y, Toyota T, et al. Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus. Diabetes 1991; 40: 52-57.
14. Tanabe T, Umegae Y, Koyashiki Y, et al. Fully automated flow-injection system for quantifying 1,5-anhydro-D-glucitol in serum. Clin Chem 1994; 40: 2006-12.
15. Bland JM, Altman DG. Calculating correlation coefficients with repeated observations: part 1 - correlation within subjects. BMJ 1995; 310: 446.
16. Yamanouchi T, Tachibana Y, Akanuma H, et al. Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body. Am J Physiol 1992; 263: E268-73.
17. Yamanouchi T, Akanuma H, Takaku F, Akanuma Y. Marked depletion of plasma 1,5-anhydroglucitol, a major polyol, in streptozocin-induced diabetes in rats and the effect of insulin treatment. Diabetes 1986; 35: 204-09.
18. Suzuki M, Akanuma H, Akanuma Y. Transport of 1,5-anhydro-D-glucitol across plasma membranes in rat hepatoma cells. J Biochem 1988; 104: 956-59.
19. Okuno Y, Nishizawa Y, Kawagishi T, Sekiya K, Shoji T, Morii H. Transport of 1,5-anhydro-D-glucitol into human polymorphonuclear leukocytes. J Biochem 1992; 111: 99-102.
20. Yamanouchi T, Tachibana Y, Sekino N, Akanuma H, Akaoka I, Miyashita H. Transport and accumulation of 1,5-anhydro-D-glucitol in the human erythroleukemia cell line K-562. J Biol Chem 1994; 269: 9664-68.
21. 1c and 1,5-anhydroglucitol. Metabolism 1992; 41: 862-67.
22. 1c? Diabetes Care 1993; 16: 1049-50.
23. Robertson DA, Rafique G, Robinson P, Bartlett K, Alberti KG. Serum anhydroglucitol as a diagnostic test for diabetes mellitus. Diabetic Med 1991; 8 (suppl 1): 22A.
24. Robertson DA, Alberti KG, Dowse GK, Zimmet P, Tuomilehto J, Gareeboo H. Is serum anhydroglucitol an alternative to the oral glucose tolerance test for diabetes screening? Diabetic Med 1993; 10: 56-60.
25. Frattali AL, Wolf BA. 1,5-anhydroglucitol: a novel serum marker for screening and monitoring diabetes mellitus? Clin Chem 1994; 40: 1991-93.
26. Kishimoto M, Yamasaki Y, Kubota M, et al. 1,5-anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM. Diabetes Care 1995; 18: 1156-59.
27. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care 1992; 15: 1835-43.